Previous Close | 480.30 |
Open | 481.89 |
Bid | 489.82 x 100 |
Ask | 491.27 x 200 |
Day's Range | 480.05 - 493.94 |
52 Week Range | 340.83 - 510.64 |
Volume | |
Avg. Volume | 1,193,750 |
Market Cap | 126.573B |
Beta (5Y Monthly) | 0.39 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.97 |
Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 513.97 |
As of August 2024, major U.S. stock indexes have experienced declines ahead of Federal Reserve Chair Jerome Powell's anticipated speech, with the S&P 500 and Nasdaq Composite shedding significant points. Despite this volatility, certain stocks may still be trading below their estimated value, presenting potential opportunities for investors. In a market characterized by fluctuating indices and economic resilience, identifying undervalued stocks requires a keen eye for companies with strong...
Vertex Pharmaceuticals has a lot going for it.
Texas Instruments, Union Pacific, Vertex Pharmaceuticals, Tile Shop and Gencor are included in this Analyst Blog.